Skip to main content
. 2010 Dec 20;9:317. doi: 10.1186/1476-4598-9-317

Figure 2.

Figure 2

Expression of miR-342 is suppressed in primary breast tumors associated with tamoxifen failure. (A,B) Photomicrograph of primary breast tumors stained for miR-342 expression by ISH from patients that (A) responded or (B) failed tamoxifen therapy. (C) Scatter plot of primary breast tumor miR-342 ISH scores (range 0-3 with 3 highest staining levels) from 10 responders and 6 non-responders during tamoxifen treatment.

HHS Vulnerability Disclosure